TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 0.760nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 0.900nMAssay Description:Inhibition of recombinant His-tagged CBP (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 0.910nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 0.940nMAssay Description:Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged CBP measured after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 0.970nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 0.997nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein [1081-1197](Homo sapiens (Human))
Board of Regents, The University of Texas System
US Patent
Board of Regents, The University of Texas System
US Patent
Affinity DataIC50: 1nMAssay Description:5 nM GST-CBP(1081-1197) and 20 nM biotin-H4(1-21) Ac-K5/8/12/16 (AnaSpec. 64989) were incubated with varying concentrations of CBP inhibitors in 15 &...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged CBP measured after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged CBP measured after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein [1081-1197](Homo sapiens (Human))
Board of Regents, The University of Texas System
US Patent
Board of Regents, The University of Texas System
US Patent
Affinity DataIC50: 1nMAssay Description:5 nM GST-CBP(1081-1197) and 20 nM biotin-H4(1-21) Ac-K5/8/12/16 (AnaSpec. 64989) were incubated with varying concentrations of CBP inhibitors in 15 &...More data for this Ligand-Target Pair
TargetCREB-binding protein [1081-1197](Homo sapiens (Human))
Board of Regents, The University of Texas System
US Patent
Board of Regents, The University of Texas System
US Patent
Affinity DataIC50: 1nMAssay Description:5 nM GST-CBP(1081-1197) and 20 nM biotin-H4(1-21) Ac-K5/8/12/16 (AnaSpec. 64989) were incubated with varying concentrations of CBP inhibitors in 15 &...More data for this Ligand-Target Pair
TargetCREB-binding protein [1081-1197](Homo sapiens (Human))
Board of Regents, The University of Texas System
US Patent
Board of Regents, The University of Texas System
US Patent
Affinity DataIC50: 1nMAssay Description:5 nM GST-CBP(1081-1197) and 20 nM biotin-H4(1-21) Ac-K5/8/12/16 (AnaSpec. 64989) were incubated with varying concentrations of CBP inhibitors in 15 &...More data for this Ligand-Target Pair
TargetCREB-binding protein [1081-1197](Homo sapiens (Human))
Board of Regents, The University of Texas System
US Patent
Board of Regents, The University of Texas System
US Patent
Affinity DataIC50: 1nMAssay Description:5 nM GST-CBP(1081-1197) and 20 nM biotin-H4(1-21) Ac-K5/8/12/16 (AnaSpec. 64989) were incubated with varying concentrations of CBP inhibitors in 15 &...More data for this Ligand-Target Pair
TargetCREB-binding protein [1081-1197](Homo sapiens (Human))
Board of Regents, The University of Texas System
US Patent
Board of Regents, The University of Texas System
US Patent
Affinity DataIC50: 1nMAssay Description:5 nM GST-CBP(1081-1197) and 20 nM biotin-H4(1-21) Ac-K5/8/12/16 (AnaSpec. 64989) were incubated with varying concentrations of CBP inhibitors in 15 &...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.07nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.10nMAssay Description:Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged CBP measured after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.10nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.13nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.15nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.16nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.17nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.20nMAssay Description:Inhibition of recombinant His-tagged CBP (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.20nMAssay Description:Inhibition of recombinant His-tagged CBP (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.20nMAssay Description:Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged CBP measured after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.20nMAssay Description:Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged CBP measured after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.39nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.40nMAssay Description:Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged CBP measured after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.42nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.45nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.5nMAssay Description:Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged CBP measured after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.5nMAssay Description:Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged CBP measured after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.5nMAssay Description:Inhibition of His6-tagged human CBP bromodomain (1081 to 1197 residues) expressed in Escherichia coli BL21 (DE3) incubated for 30 mins by HTRF assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.54nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.71nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.85nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.90nMAssay Description:Inhibition of His6-tagged human CBP bromodomain (1081 to 1197 residues) expressed in Escherichia coli BL21 (DE3) incubated for 30 mins by HTRF assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.91nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 1.92nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein [1081-1197](Homo sapiens (Human))
Board of Regents, The University of Texas System
US Patent
Board of Regents, The University of Texas System
US Patent
Affinity DataIC50: 2nMAssay Description:5 nM GST-CBP(1081-1197) and 20 nM biotin-H4(1-21) Ac-K5/8/12/16 (AnaSpec. 64989) were incubated with varying concentrations of CBP inhibitors in 15 &...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 2nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 2nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 2nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 2nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 2nMAssay Description:Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged CBP measured after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 2nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 2nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
TargetCREB-binding protein(Homo sapiens (Human))
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.
US Patent
Affinity DataIC50: 2nMAssay Description:His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...More data for this Ligand-Target Pair
